JP2023549433A5 - - Google Patents

Info

Publication number
JP2023549433A5
JP2023549433A5 JP2023547921A JP2023547921A JP2023549433A5 JP 2023549433 A5 JP2023549433 A5 JP 2023549433A5 JP 2023547921 A JP2023547921 A JP 2023547921A JP 2023547921 A JP2023547921 A JP 2023547921A JP 2023549433 A5 JP2023549433 A5 JP 2023549433A5
Authority
JP
Japan
Prior art keywords
pna oligomer
hybridization probe
group
probe portion
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023547921A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023549433A (ja
JP7795810B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/078854 external-priority patent/WO2022079321A1/en
Publication of JP2023549433A publication Critical patent/JP2023549433A/ja
Publication of JP2023549433A5 publication Critical patent/JP2023549433A5/ja
Application granted granted Critical
Publication of JP7795810B2 publication Critical patent/JP7795810B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023547921A 2020-10-16 2021-10-18 プレターゲットイメージングおよび治療用pnaプローブ Active JP7795810B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE2051204-2 2020-10-16
SE2051204 2020-10-16
PCT/EP2021/078854 WO2022079321A1 (en) 2020-10-16 2021-10-18 Pna probes for pretargeted imaging and therapy

Publications (3)

Publication Number Publication Date
JP2023549433A JP2023549433A (ja) 2023-11-24
JP2023549433A5 true JP2023549433A5 (https=) 2024-10-23
JP7795810B2 JP7795810B2 (ja) 2026-01-08

Family

ID=78463448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547921A Active JP7795810B2 (ja) 2020-10-16 2021-10-18 プレターゲットイメージングおよび治療用pnaプローブ

Country Status (8)

Country Link
US (1) US20240148917A1 (https=)
EP (1) EP4228763A1 (https=)
JP (1) JP7795810B2 (https=)
KR (1) KR20230088731A (https=)
CN (1) CN116322784A (https=)
CA (1) CA3195446A1 (https=)
WO (1) WO2022079321A1 (https=)
ZA (1) ZA202304592B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL279489B2 (en) 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE458499T1 (de) 1995-06-07 2010-03-15 Immunomedics Inc Verbesserte abgabe von diagnostischen und therapeutischen stoffen an einem zielort
CA2531238C (en) 2003-07-04 2015-02-24 Affibody Ab Polypeptides having binding affinity for her2
US20050260131A1 (en) * 2004-05-20 2005-11-24 General Electric Company Pharmaceuticals for enhanced delivery to disease targets
DE602006020577D1 (de) 2005-07-01 2011-04-21 Dako Denmark As Monomere und polymere linker zur konjugierung von biologischen molekülen und anderen stoffen
US10113169B2 (en) * 2013-12-23 2018-10-30 Memorial Sloan-Kettering Cancer Center Methods and compositions for treating cancer using peptide nucleic acid-based agents
EP3554556B1 (en) * 2016-12-19 2022-03-09 Ventana Medical Systems, Inc. Peptide nucleic acid conjugates

Similar Documents

Publication Publication Date Title
US8865873B2 (en) Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
JP6257669B2 (ja) ヒト前立腺特異的膜抗原(psma)をターゲッティングするj591ミニボディおよびcysダイアボディならびにこれらを使用するための方法
JP2009531324A5 (https=)
TWI259837B (en) Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
JP6869187B2 (ja) ナノ粒子イムノコンジュゲート
JP5110768B2 (ja) モノクローナル抗体pam4ならびに膵臓癌の診断および治療のためのその使用
EP1781818B1 (en) CANCER AND INFLAMMATION DIAGNOSIS USING ANTI sTNFR ANTIBODIES
JP2009280607A (ja) フィブロネクチンのed−bドメインに対する抗体、それを含有する抱合体、および、腫瘍および血管新生関連の疾病の診断および治療をするためのそれの用途
US9718888B2 (en) Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)
JP2006513695A5 (https=)
Gong et al. A 3E8. scFv. Cys-IR800 conjugate targeting TAG-72 in an orthotopic colorectal cancer model
TWI780082B (zh) 新穎抗人類MUC1抗體Fab片段
CN117327182B (zh) Cldn18.2单域抗体探针的制备方法及应用
Casey et al. Tumour targeting of humanised cross-linked divalent-Fab′ antibody fragments: a clinical phase I/II study
Khawli et al. Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors
CA2956161A1 (en) Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (tag-72)
JP2020513817A (ja) ヒトfshr細胞外ドメインに対する抗体
JP2023549433A5 (https=)
CN103582497A (zh) 用于成像的基于聚苹果酸的纳米缀合物
E. Wang et al. Antibody-based imaging of HER-2: moving into the clinic
JP7708374B2 (ja) フィブリンに結合する抗体および当該抗体を含む医薬組成物
Ding et al. Development of gold nanorods conjugated with radiolabeled anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody as single-photon emission computed tomography/photoacoustic dual-imaging probes targeting HER2-positive tumors
JP2022541765A (ja) 抗grp78抗体およびその使用方法
WO2012032043A1 (en) 212 pb imaging
US11666672B2 (en) Anti-CD33 antibody-guided imaging and treatment of acute myeloid leukemia